Skip to main content
. 2017 Nov 27;96(47):e8709. doi: 10.1097/MD.0000000000008709

Figure 1.

Figure 1

Right eye visual field (A) before and (B) after treatment with glucocorticoid, rituximab, and cyclophosphamide. (A) The patient initially had an almost total visual field defect. (B) The visual field defect exhibited dramatic recovery 2 months after the initiation of immunosuppressive therapy.